Clinical & Experimental Metastasis

Papers
(The H4-Index of Clinical & Experimental Metastasis is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer67
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis57
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches54
Donald L. Morton Memorial Lecture: the legacy of Donald Morton: past, present and future45
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis39
Immunotherapy of cancer in the era of checkpoint inhibitor34
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)33
Emerging photoacoustic and thermoacoustic imaging technologies for detecting primary and metastatic cancer and guiding therapy29
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study29
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models29
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer29
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy28
Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils26
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer24
Detection of sentinel lymph nodes by tilmanocept in oral squamous cell carcinoma24
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)23
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis18
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption18
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review18
0.069756984710693